BALYASNY ASSET MANAGEMENT L.P. - TANDEM DIABETES CARE INC ownership

TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 274 filers reported holding TANDEM DIABETES CARE INC in Q1 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of TANDEM DIABETES CARE INC
ValueSharesWeighting
Q1 2023$11,378,597
-60.8%
280,192
-56.6%
0.03%
-63.3%
Q4 2022$29,032,981
+106.7%
645,895
+120.1%
0.08%
+83.7%
Q3 2022$14,045,000
+17.4%
293,520
+185.3%
0.04%
+13.2%
Q1 2022$11,965,000
-53.6%
102,891
-40.0%
0.04%
-56.8%
Q4 2021$25,811,000
-20.4%
171,478
-40.0%
0.09%
-63.0%
Q3 2020$32,429,000
+111.9%
285,720
+84.7%
0.24%
+78.9%
Q2 2020$15,302,000
+50.9%
154,694
-1.8%
0.13%
+10.8%
Q1 2020$10,138,000
-58.4%
157,543
-61.5%
0.12%
-17.2%
Q4 2019$24,381,000
+89.8%
409,014
+87.7%
0.14%
+64.8%
Q3 2019$12,849,000
-22.5%
217,853
-15.3%
0.09%
-17.0%
Q2 2019$16,588,000
+6183.3%
257,093
+6072.7%
0.11%
+5200.0%
Q1 2019$264,000
-92.0%
4,165
-95.2%
0.00%
-91.7%
Q4 2018$3,282,000
+29.9%
86,435
+46.6%
0.02%
+118.2%
Q3 2018$2,526,000
-72.4%
58,973
-85.8%
0.01%
-73.2%
Q2 2018$9,138,000
+540.8%
415,000
+44.3%
0.04%
+583.3%
Q1 2018$1,426,000287,5000.01%
Other shareholders
TANDEM DIABETES CARE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 474,929$22,725,0003.92%
Soleus Capital Management, L.P. 415,200$19,867,0002.70%
First Light Asset Management, LLC 485,620$23,237,0002.35%
Eagle Health Investments LP 196,400$9,398,0002.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 218,049$10,434,0001.66%
EMINENCE CAPITAL, LP 1,590,787$76,119,0001.59%
Brown Capital Management 2,010,230$96,190,0001.35%
Chicago Capital, LLC 479,873$22,962,0001.33%
Intrinsic Edge Capital Management LLC 247,391$11,838,0001.29%
Bellevue Group AG 1,566,015$74,933,0001.08%
View complete list of TANDEM DIABETES CARE INC shareholders